Cost‐effectiveness analysis of epidural morphine/ropivacaine treatment in patients with cancer pain

Background Cancer pain is one of the main causes of human suffering, which can generate disabilities and compromise quality of life, giving rise to several psychosocial and economic consequences. Aims This quantitative study sought to perform a cost‐effectiveness pharmacoeconomic analysis to assess...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pain practice 2024-01, Vol.24 (1), p.25-41
Hauptverfasser:	Vieira, Liliana Batista, Barros, Carlos Marcelo, Price, Price Udo, Podestá, Márcia Helena Miranda Cardoso, Pereira, Samea Araújo, Itria, Alexander, Torres, Larissa Helena, Pereira, Leonardo Régis Leira
Format:	Artikel
Sprache:	eng
Schlagworte:	cost‐effectiveness analysis epidural morphine gastrointestinal cancer health technology assessments pain pain visual analog scale pharmacoeconomics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!